Sudeep Nagaraj | Immunotherapy | Best Researcher Award

Sudeep Nagaraj | Immunotherapy | Best Researcher Award

Dr. Sudeep Nagaraj, ICAR-NIVEDI, India

Dr. Sudeep Nagaraj is an accomplished molecular biologist and research scientist with a Ph.D. from GITAM University (2025) πŸŽ“. He possesses extensive hands-on expertise in molecular genetics, cytogenetics, proteomics, virology, and phytochemistry πŸ§ͺ🌿. With over six years of academic and research experience, he has served in various prestigious institutions including ICAR-NIVEDI and ICAR-IVRI πŸ›οΈ. Dr. Nagaraj has authored 20+ peer-reviewed publications on cytotoxicity, DNA barcoding, and viral epidemiology πŸ“š. His primary research focus lies in virology and molecular diagnostics, especially lumpy skin disease in livestock πŸ„πŸ¦ . He is known for blending academic rigor with applied research for public health impact πŸ’‘.

Publication Profile

Google Scholar

Education

Dr. Sudeep Nagaraj holds a Ph.D. in Molecular Biology from GITAM University (2025) 🧬, an MSc from SDUAHER, Tamaka Kolar (2016) πŸ§ͺ, and a BSc from FGC, KGF (2012) πŸ“š. His academic journey began at Chinmaya Vidyalaya, Kolar (SSLC, 2007) and continued through BGS PU College (PUC, 2009) 🏫. Professionally, he has accumulated diverse experience across esteemed research institutions and labs, contributing significantly to molecular and virology research 🧫. Additionally, he has one year of teaching experience in Molecular Biology at SIMS and RC, where he taught undergraduate students with dedication and clarity πŸŽ“πŸ§‘β€πŸ«.

Experience

oDr. Sudeep Nagaraj has amassed rich experience through roles such as SRF at ICAR-NIVEDI (2021–present) 🧬, Young Professional-II at ICAR-IVRI (2020–2021) 🧫, and Research Scientist at Cytogene Diagnostics (2019–2020) πŸ”¬. His journey also includes positions at SIMS and RC, QTLomics, and IDBR. He taught Molecular Biology at SIMS and RC for a year at the UG level πŸŽ“. His hands-on skills span molecular genetics (PCR, DNA isolation, HRM), proteomics (SDS-PAGE, Bradford assay), cytogenetics (karyotyping), gene cloning, cell culture, virology (ELISA, virus titration), and phytochemistry (plant extract prep) 🧬🌿🧫.

Awards

Dr. Sudeep Nagaraj has been honored with several prestigious awards for his outstanding contributions to scientific research and innovation πŸ§ πŸ”¬. He received the Young Scientist Award at the International Conference on Science, Health, and Engineering held in Chennai on January 11, 2020 πŸ†. In 2021, he was conferred the Best Researcher Award at the International Research Awards on New Science Inventions on August 11 in Chennai πŸ₯‡. Most recently, in 2025, he was recognized once again with a Young Scientist Award from Scientific Laurels, celebrating his continued excellence in research πŸš€πŸ“š.

Research Focus

Dr. Sudeep Nagaraj’s research centers around molecular virology, cytogenetics, and immunology, with a significant emphasis on Lumpy Skin Disease (LSD) in livestock πŸ„. His work extends to plant-based cytotoxicity, DNA barcoding, and cell culture techniques, reflecting a strong interdisciplinary foundation 🌿πŸ§ͺ. His studies explore pathogen-host interactions, viral evolution, and molecular diagnostics, contributing vital insights into disease spillovers and viral epidemiology across species πŸ§ πŸ”. He also focuses on PBMC assays, ELISA, and nanoparticle toxicity, bridging biomedicine, virology, and phytochemistry. His impactful contributions aid in zoonotic disease management and therapeutic development πŸ“ŠπŸ’‰πŸŒΎ.

Publication Top Notes

Lumpy Skin Disease (LSD) in Yak (Bos grunniens): An Evidence of Species Spillover from Cattle in India

Evaluation of In Vitro Cytotoxic Effects of Three Medicinal Plants on Peripheral Blood Mononuclear Cells (PBMC)

First evidence of lumpy skin disease in mithun (Bos frontalis) in India

An in vitro cytotoxic and genotoxic properties of Allamanda cathartica L. Latex green NPs on human peripheral blood mononuclear cells

Unravelling the genomic origins of lumpy skin disease virus in recent outbreaks

Evaluation of HCP5 and Chemokine C receptor type 5 gene polymorphisms in Indian psoriatic patients

DNA based identification of species of Zingiberaceae family plants using Bar-Hrm analysis

A SIMPLE, COSTΒ­EFFECTIVE, FAST AND EASY TO ISOLATE DNA PROTOCOL FROM HUMAN SAMPLES

Investigation of Comorbidity and Risk Analysis During Lumpy Skin Disease Outbreaks in India

Evaluation of invitro cytotoxic activity of parts of Murraya koenigii (curry) plant on human peripheral blood mononuclear cells

Separation and Optimisation of a Sucrose Density Gradient Centrifugation Protocol for Isolation of Peripheral Blood Mononuclear Cells (PBMC)

Fast and Easy Protocol of DNA Extraction from Fresh and Hard/Dried Plant Samples of Indian Spices

Konstantinos Tsapakidis | Immunotherapy | Excellence in Research

Konstantinos Tsapakidis | Immunotherapy | Excellence in Research

Assist. Prof. Dr. Konstantinos Tsapakidis, University Hospital Of Larissa, Greece

Assist. Prof. Dr. Konstantinos Tsapakidis πŸŽ“πŸ‘¨β€βš•οΈ is an esteemed Medical Oncologist at the University of Thessaly, Greece. With a Ph.D. focused on prostate cancer research, he holds European Certification in Medical Oncology πŸ…. Since 2018, he has been actively involved in clinical oncology, teaching postgraduate courses on cancer, diet, and immunotherapy 🍽️🧬. Dr. Tsapakidis has authored numerous impactful publications πŸ“š, contributing significantly to cancer diagnostics and treatment. Passionate about education, he trains residents and nurses, advancing oncology knowledge. His expertise includes systemic antineoplastic therapies and immune-oncology 🌟.

Publication Profile

Orcid

Education

Assist. Prof. Dr. Konstantinos Tsapakidis πŸŽ“ is a dedicated Medical Oncologist with an impressive educational background. He earned his Biology degree from Aristotelian University of Thessaloniki 🧬 (1998–2002) and completed his Medicine degree at the University of Thessaly πŸ₯ (2003–2007). Dr. Tsapakidis achieved his Ph.D. with excellence (2005–2012), researching prostate cancer’s cell-cycle and apoptosis mechanisms πŸ”¬. He specialized in Medical Oncology in 2017 🎯 and obtained the prestigious European Certification in Medical Oncology in 2018 πŸ…. He also enhanced his expertise through an Immune-Oncology e-learning program at the University of Piraeus in 2017–2018 πŸ’».

Experience

Assist. Prof. Dr. Konstantinos Tsapakidis πŸ’Ό has extensive medical oncology experience. Since February 2025, he serves as Assistant Professor at the University of Thessaly πŸŽ“. From 2018 to 2025, he worked as Consultant in Medical Oncology at University Hospital of Larissa πŸ₯. Previously, he was a University Scholar and Fellow Consultant there (2017–2018) πŸ‘¨β€βš•οΈ. He completed his residency in Medical Oncology (2014–2017) and earlier trained in Internal Medicine and Hematology at Larissa hospitals 🩺. Between 2008–2009, he was a Scientific Associate in Medical Oncology, laying a strong foundation for his clinical career πŸ”¬.

Research Focus

Assist. Prof. Dr. Konstantinos Tsapakidis’s research focus lies primarily in Medical Oncology with a strong emphasis on cancer diagnosis, treatment, and immunotherapy. 🧬🩺 His work explores various cancer types including lung cancer, breast cancer, sarcomas, and rare cancers, investigating immunotherapy responses, molecular diagnostics, and tumor behavior. πŸ”¬πŸ’‰ He is particularly involved in studying biomarkers like PD-1/PD-L1, immune cell profiling, and novel therapeutic approaches to improve patient outcomes. πŸ§ͺβš•οΈ His research also covers cancer-associated complications like thrombosis and metastatic disease. Overall, his contributions advance personalized oncology care and innovative cancer treatment strategies.

Publication Top Notes

Pseudomyxoma Peritonei: A Challenging Clinical Diagnosis. Case Report and Review of the Literature

The Impact of Expert Pathology Review and Molecular Diagnostics on the Management of Sarcoma Patients: A Prospective Study of the Hellenic Group of Sarcomas and Rare Cancers

Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients

ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment

Combinatorial analysis of CD4<SUP>+</SUP>Tregs and CD8<SUP>+</SUP>Teff to predict response to ICI in patients with ES-SCLC

Metachronous Single Pulmonary Metastasis of Prostate Cancer: Report of a Rare Case and Literature Review

SYNCHRONOUS DIAGNOSIS OF TESTICULAR AND THYROID CANCER IN A YOUNG MALE

A Proposed Nomogram Model for Recurrence of Non-Muscle Invasive Bladder Carcinoma COMMENT

Metastatic rectal cancer in the ampulla of Vater: A unique case

Radiotherapy and Breast Reconstruction: What Is the Ideal Timing? A Narrative Review

Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden